000 01059 a2200301 4500
005 20250511230158.0
264 0 _c19901119
008 199011s 0 0 eng d
022 _a0142-2782
024 7 _a10.1002/bdd.2510110608
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMorse, I S
245 0 0 _aPharmacokinetics and safety of single oral doses of lomefloxacin.
_h[electronic resource]
260 _bBiopharmaceutics & drug disposition
_c
300 _a543-51 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _a4-Quinolones
650 0 4 _aAdult
650 0 4 _aAnti-Infective Agents
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aFluoroquinolones
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aQuinolones
773 0 _tBiopharmaceutics & drug disposition
_gvol. 11
_gno. 6
_gp. 543-51
856 4 0 _uhttps://doi.org/10.1002/bdd.2510110608
_zAvailable from publisher's website
999 _c2213438
_d2213438